https://www.selleckchem.com/pr....oducts/tocilizumab.h
uggested that EMP1 may be used as a predictive biomarker to determine the prognosis and immune infiltration in BLCA.The present study aimed to elucidate the genetic features of multiple lung cancer (MLC) and identify effective molecular markers for diagnosis using next generation sequencing (NGS). The present data may also inform patient treatment and prognosis. A total of 35 lesions were obtained from 17 patients with MLC. Based on lesion histology and NGS, 13 cases of multiple primary lung cancer (MPLC) were identified and 4 cases
Like
Comment
Share
